Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes

To study efficiency of molgramostim as an adjuvant in HBV vaccination we randomized 18 pts after OLT due to non-HBV causes. Nine pts received GM-CSF (150 mcg of sc 24 h before 1st dose of vaccine). Other 9 pts received only vaccine. Both groups of pts did not differ in sex, age, immunosuppression an...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: V. E. Syutkin, A. A. Saliyenko, D. E. Syutkina, A. V. Chzhao
التنسيق: مقال
اللغة:English
منشور في: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
سلاسل:Трансплантология (Москва)
الموضوعات:
الوصول للمادة أونلاين:https://www.jtransplantologiya.ru/jour/article/view/289